Richard C.K. Jordan, DDS, PhD


Professor, Departments of Orofacial Sciences and Pathology, UCSF

Phone: (415) 476-8233 (voice)
Box 0424, UCSF
San Francisco, CA 94143-0424

View on UCSF Profiles


University of Toronto, D.D.S., 1986, Dentistry
University of Toronto, M.Sc., 1992, Oral Pathology
University of London (UK), Ph.D., 1995, Experimental Pathology

Professional Experience

  • 1986-1987
    Intern; Toronto Western Hospital, Toronto, Canada
  • 1987-1988
    General dental practice; Newmarket, Ontario, Canada
  • 1988-1989
    Resident in anatomic pathology; Toronto Western Hospital, Toronto, Canada
  • 1989-1991
    Resident in Oral Pathology; University of Toronto
  • 1991
    Research Fellow; Canadian Reference Centre for Cancer Pathology, Ottawa, Canada
  • 1992-1995
    Medical Research Council of Canada Research Fellow, U. London, London, UK
  • 1994
    Research Fellow; Department of Haematology; Kanazawa Medical University, Kanazawa, Japan
  • 1995-2000
    Oral Pathologist; Sunnybrook & Women's College Health Sciences Centre, Toronto, Canada
  • 1995-2000
    Assistant Professor; Faculty of Dentistry, University of Toronto
  • 1995-2000
    Assistant Professor, Faculty of Medicine, Dept. of Lab Medicine & Pathobiology, University of Toronto
  • 2000-2001
    Associate Professor, Faculty of Dentistry, University of Toronto
  • 2001-present
    Professor & Vice Chair, Department of Orofacial Sciences & Department of Pathology, UCSF

Honors & Awards

  • 1981
    Senate Scholarship, U. Western Ontario
  • 1985
    Wroblewski Award; Mosby Prize; Murray Cornish Scholarship
  • 1986
    Xi Xsi Phi prize; Deans Honour List
  • 1991
    U. Toronto Open Fellowship; Canadian Fund for Dental Education Award
  • 1994
    International Association of Oral Pathology Award
  • 1995
    International Association for Dental Research prize in Experimental Pathology

Selected Publications

  1. Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT. Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity. J Clin Oncol. 2014 Dec 1; 32(34):3858-67.
    View on PubMed
  2. Schulman JM, Jordan RC. Oral mucus extravasation phenomenon with myxoglobulosis. J Cutan Pathol. 2014 Oct; 41(10):767-70.
    View on PubMed
  3. Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, Raben D, Gillison ML, Jordan RC, Le QT. p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2014 Dec 10; 32(35):3930-8.
    View on PubMed
  4. Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50.
    View on PubMed
  5. Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Rotman M, Khuntia D, Straube W, Zhang Q, Ang K. Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol. 2014 Aug 10; 32(23):2486-95.
    View on PubMed
  6. Dawson AL, Schulman JM, Jordan RC, North JP. Ossifying fibroma in Buschke-Ollendorff syndrome. J Cutan Pathol. 2014 Sep; 41(9):740-4.
    View on PubMed
  7. Kong CS, Cao H, Kwok S, Nguyen CM, Jordan RC, Beaudry VG, Attardi LD, Le QT. Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jan; 115(1):95-103.
    View on PubMed
  8. Yang F, Liu R, Kramer R, Xiao W, Jordan R, Lam KS. Discovery of specific ligands for oral squamous carcinoma to develop anti-cancer drug loaded precise targeting nanotherapeutics. J Calif Dent Assoc. 2012 Dec; 40(12):939-43.
    View on PubMed
  9. Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013 Jan; 49(1):1-8.
    View on PubMed
  10. Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012 Jul; 36(7):945-54.
    View on PubMed
  11. Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol. 2012 Jun 10; 30(17):2102-11.
    View on PubMed
  12. Van Loon K, Gill RM, McMahon P, Chigurupati R, Siddiqi I, Fox L, Damon L, McCalmont TH, Jordan R, Wolf J. 20q- clonality in a case of oral sweet syndrome and myelodysplasia. Am J Clin Pathol. 2012 Feb; 137(2):310-5.
    View on PubMed
  13. Weinberger DM, Simonsen L, Jordan R, Steiner C, Miller M, Viboud C. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis. 2012 Feb 1; 205(3):458-65.
    View on PubMed
  14. Verstraete FJ, Zin BP, Kass PH, Cox DP, Jordan RC. Clinical signs and histologic findings in dogs with odontogenic cysts: 41 cases (1995?2010). J Am Vet Med Assoc. 2011 Dec 1; 239(11):1470-6.
    View on PubMed
  15. Peacock ZS, Jordan RC, Schmidt BL. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior? J Oral Maxillofac Surg. 2012 Aug; 70(8):1860-6.
    View on PubMed
  16. Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, Bengtsson H, Jordan RC, Olshen AB, Pinkel D, Schmidt BL, Albertson DG. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res. 2011 Nov 15; 17(22):7024-34.
    View on PubMed
  17. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011 Nov 10; 29(32):4294-301.
    View on PubMed
  18. Solar AA, Jordan RC. Soft tissue tumors and common metastases of the oral cavity. Periodontol 2000. 2011 Oct; 57(1):177-97.
    View on PubMed
  19. Gilbert J, Murphy B, Dietrich MS, Henry E, Jordan R, Counsell A, Wirth P, Yarbrough WG, Slebos RJ, Chung CH. Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Cancer. 2012 Feb 15; 118(4):1007-13.
    View on PubMed
  20. Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, Umehara H, Zhao Y, Challacombe S, Lam MY, De Souza Y, Schiødt J, Holm H, Bisio PA, Gandolfo MS, Sawaki T, Li M, Zhang W, Varghese-Jacob B, Ibsen P, Keszler A, Kurose N, Nojima T, Odell E, Criswell LA, Jordan R, Greenspan JS. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum. 2011 Jul; 63(7):2021-30.
    View on PubMed

Go to UCSF Profiles, powered by CTSI